Illumina, PacBio Call Off $1.2B Merger Amid FTC Probe
Illumina Inc.'s planned $1.2 billion purchase of fellow DNA sequencing company Pacific Biosciences was called off Thursday in an apparent concession to antitrust pressure, particularly a Federal Trade Commission merger challenge....To view the full article, register now.
Already a subscriber? Click here to view full article